Infinity Pharmaceuticals Stock Price To Book
| INFIQ Stock | 0.0001 0.00 0.00% |
Infinity Pharmaceuticals fundamentals help investors to digest information that contributes to Infinity Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Infinity Stock. The fundamental analysis module provides a way to measure Infinity Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infinity Pharmaceuticals stock.
As of 11/28/2024, Price To Book Ratio is likely to grow to -2.84. Infinity | Price To Book |
Infinity Pharmaceuticals Company Price To Book Analysis
Infinity Pharmaceuticals' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Infinity Pharmaceuticals Price To Book | 8.03 X |
Most of Infinity Pharmaceuticals' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Infinity Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for Infinity Pharmaceuticals is extremely important. It helps to project a fair market value of Infinity Stock properly, considering its historical fundamentals such as Price To Book. Since Infinity Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Infinity Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Infinity Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Infinity Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, Infinity Pharmaceuticals has a Price To Book of 8.0285 times. This is 68.74% lower than that of the Biotechnology sector and 32.92% higher than that of the Health Care industry. The price to book for all United States stocks is 15.58% higher than that of the company.
Infinity Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Infinity Pharmaceuticals' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Infinity Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Infinity Pharmaceuticals by comparing valuation metrics of similar companies.Infinity Pharmaceuticals is currently under evaluation in price to book category among its peers.
Infinity Fundamentals
| Return On Asset | -0.61 | ||||
| Operating Margin | (17.36) % | ||||
| Current Valuation | (17.1 M) | ||||
| Shares Outstanding | 90.76 M | ||||
| Shares Owned By Insiders | 2.68 % | ||||
| Number Of Shares Shorted | 2.21 M | ||||
| Price To Book | 8.03 X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 2.59 M | ||||
| Gross Profit | (31.38 M) | ||||
| EBITDA | (43.73 M) | ||||
| Net Income | (44.37 M) | ||||
| Total Debt | 917 K | ||||
| Book Value Per Share | (0.41) X | ||||
| Cash Flow From Operations | (42.43 M) | ||||
| Short Ratio | 0.31 X | ||||
| Earnings Per Share | (0.46) X | ||||
| Target Price | 0.3 | ||||
| Number Of Employees | 30 | ||||
| Beta | 1.33 | ||||
| Market Capitalization | 9.08 K | ||||
| Total Asset | 42.15 M | ||||
| Retained Earnings | (855.95 M) | ||||
| Working Capital | 26.67 M | ||||
| Net Asset | 42.15 M |
About Infinity Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Infinity Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Infinity Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infinity Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Infinity Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Infinity Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Infinity Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Infinity Pharmaceuticals to buy it.
The correlation of Infinity Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Infinity Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Infinity Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Infinity Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.